Product Details
Auro-Liothyronine
Liothyronine (Sodium)25 mcg
Tablet
DIN/PIN/NPN
02550008
Manufacturer
Auro Pharma Inc.
Formulary Listing Date
2025-11-28
Unit Price
1.2595
Amount MOH Pays
1.2595
Coverage Status
Off-Formulary Interchangeable Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
H03AA02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 01919466 | Cytomel | NA | NA |
| 02494345 | Teva-Liothyronine | 1.2595 | 1.2595 |
| 02550008 | Auro-Liothyronine | 1.2595 | 1.2595 |
| 02561301 | ZDS-Liothyronine | 1.2595 | 1.2595 |
LU Clinical Criteria
NORequirements
EAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – August 8, 2023 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |